{"id":52140,"date":"2025-09-17T14:08:40","date_gmt":"2025-09-17T14:08:40","guid":{"rendered":"https:\/\/my.legal500.com\/developments\/?post_type=press_releases&p=52140"},"modified":"2025-09-17T14:11:54","modified_gmt":"2025-09-17T14:11:54","slug":"gsk-stockmann-advises-art-invest-real-estate-on-sale-of-momenturm-in-munichs-werksviertel-district","status":"publish","type":"press_releases","link":"https:\/\/my.legal500.com\/developments\/press-releases\/gsk-stockmann-advises-art-invest-real-estate-on-sale-of-momenturm-in-munichs-werksviertel-district\/","title":{"rendered":"GSK Stockmann advises Art-Invest Real Estate on sale of Momenturm in Munich\u2019s Werksviertel district"},"content":{"rendered":"

GSK\u00a0Stockmann advised Art-Invest Real Estate on the sale of the Momenturm office building, located in Munich\u2019s Werksviertel district, to Generali. The European commercial law firm has provided ongoing support to Art-Invest Real Estate with the project since the initial acquisition of the property.<\/strong><\/p>\n

<\/p>\n

Art-Invest Real Estate has sold the Momenturm project to Generali Deutschland. The transaction was carried out by Generali Real Estate S.p.A. on behalf of Generali Deutschland. The existing approx. 11,000 sqm of office space in the building, located at Rosenheimer Strasse 139, just a stone\u2019s throw away from Munich Ostbahnhof, is to be extended to around 28,000 sqm. Generali Deutschland plans to use the building as its new corporate headquarters, with 1,500 employees expected to be relocated there.<\/p>\n

A GSK\u00a0Stockmann team led by Munich-based partner Dirk Br\u00fcckner has been providing Art-Invest Real Estate with comprehensive support on this project since it first acquired the property back in 2019. The firm\u2019s advice encompassed project structuring, project development and securing planning permission, as well as the sale to Generali.<\/p>\n

Art-Invest Real Estate is a long-standing client of GSK\u00a0Stockmann. Most recently, the law firm advised the company on the acquisition of a hotel portfolio in 2024, which included properties in Berlin, Oberhausen, Koblenz and Frechen near Cologne. Other past projects include the acquisition of the Wangen office campus in Stuttgart and the Arnulfbogen in Munich, both in 2021, as well as the commercial property F150 on the Frankfurter Ring in Munich and the City-Passage in Wiesbaden, both in 2022.<\/p>\n

Advisers of Art-Invest Real Estate at GSK\u00a0Stockmann:<\/u><\/p>\n

Dr Dirk Br\u00fcckner (lead), Dr Mark Butt (both Real Estate Transactions & Investments), Stefan Dorn (Project Development), Stefan Wachsmuth (Tax), Katharina Feierabend (Real Estate Transactions & Investments); Associates: Sebastian Gerhards (Tax), Maximiliane Bartsch, Melanie Patrizia Seitz (both Real Estate Transactions & Investments), Leonie Lindenbu\u00df (Project Development)<\/p>\n

\"\"<\/p>\n

GSK M\u00fcnchen<\/p>\n\n\n\n
Contact:<\/strong><\/p>\n

GSK STOCKMANN<\/p>\n

Dr Dirk Br\u00fcckner<\/p>\n

Karl-Scharnagl-Ring 8<\/p>\n

80539 Munich<\/p>\n

T +49 89 288174\u200a-\u200a71<\/p>\n

F +49 89 288174-44<\/p>\n

dirk.brueckner@gsk.de<\/a><\/td>\n

Press contact:<\/strong><\/p>\n

GSK STOCKMANN<\/p>\n

Christina Holl<\/p>\n

Karl-Scharnagl-Ring 8<\/p>\n

80539 Munich<\/p>\n

T +49 89 288174-275<\/p>\n

F +49 89 288 174-44<\/p>\n

presse@gsk.de<\/a><\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n

 <\/p>\n

GSK Stockmann is a leading independent European corporate law firm. Over 250 professionals advise German and international clients at our locations in Berlin, Frankfurt\/M., Hamburg, Heidelberg, Munich, Luxembourg and London. GSK is the law firm of choice for Real Estate and Financial Services. We also have deep-rooted expertise in key sectors including Funds, Capital Markets, Public, Mobility, Energy and Healthcare. For international transactions and projects, we work together with selected reputable law firms abroad. Our advice combines an economic focus with entrepreneurial foresight. That is what is behind:\u00a0 Your perspective.<\/strong><\/p>\n

More about us: www.gsk.de<\/p>\n

 <\/p>\n","protected":false},"featured_media":0,"template":"","class_list":["post-52140","press_releases","type-press_releases","status-publish","hentry"],"acf":[],"_links":{"self":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases\/52140","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/press_releases"}],"about":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/types\/press_releases"}],"wp:attachment":[{"href":"https:\/\/my.legal500.com\/developments\/wp-json\/wp\/v2\/media?parent=52140"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}